Catalent Inc

CTLT

Company Profile

  • Business description

    Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

  • Contact

    14 Schoolhouse Road
    SomersetNJ08873
    USA

    T: +1 732 537-6200

    E: [email protected]

    https://www.catalent.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    30 June 2025

    Employees

    16,900

Catalent Inc News & Analysis

stocks

11 stocks to examine through a sustainability lens

Investors can use ESG information in many useful ways.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,450.9064.30-0.76%
CAC 407,236.859.870.14%
DAX 4019,066.6332.990.17%
Dow JONES (US)43,910.98382.15-0.86%
FTSE 1008,031.836.060.08%
HKSE19,823.4523.43-0.12%
NASDAQ19,281.4017.36-0.09%
Nikkei 22538,721.66654.43-1.66%
NZX 50 Index12,674.4974.87-0.59%
S&P 5005,983.9917.36-0.29%
S&P/ASX 2008,193.4062.20-0.75%
SSE Composite Index3,439.2817.310.51%

Market Movers